SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i

BlackRock Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ: ICUI) during the unde

Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ: ICUI) during the

California State Teachers Retirement System grew its stake in shares of ICU Medical, Inc. (NASDAQ: I

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and rais

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 g

BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target

Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price t

ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript

ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% o

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business perfo

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus

ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 an

ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 a

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst cons

SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in

SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises th

This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support port

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medi

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medi

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's ana

BTIG analyst Sam Eiber initiates coverage on ICU Medical (NASDAQ:ICUI) with a Buy rating and anno

2,447 shares sold for a transaction value of ~$304,000. This sale represented 11.17% of Sanzone's di

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-iv-tubing-se

Top Wall Street analysts upgraded ICUI, PSX, PARR, and GPOR and raised price targets. Check out anal

Investors need to pay close attention to ICUI stock based on the movements in the options market lat

ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript

ICU Medical (ICUI) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus

ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $1.03-$1.74 to $1.03-$1.74 vs $1.73

ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $7.75-$8.45 to $7.75-$8.45 vs $8.09 a

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.97 per share which beat the analyst cons

SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers th

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowe

Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises th

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and rais

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.91 per share which beat the analyst cons

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/intravascular-administra

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises th

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and rais

ICU Medical (NASDAQ:ICUI) raises FY2025 Adj EPS guidance from $6.85-$7.15 to $7.35-$7.65 vs $6.99 an

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.03 per share which beat the analyst cons